Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma

被引:6
|
作者
Zhang, Shiqiang [1 ]
Zheng, Wenzhong [2 ]
Jiang, Donggen [1 ]
Xiong, Haiyun [1 ]
Liao, Guolong [1 ]
Yang, Xiangwei [1 ]
Ma, He [1 ]
Li, Jun [1 ]
Qiu, Miaojuan [3 ]
Li, Binbin [3 ]
Sun, Chunhui [3 ]
Zhao, Jing [3 ]
Wang, Liling [4 ]
Pang, Jun [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Urol, Shenzhen, Peoples R China
[2] Fujian Med Univ Union Hosp, Dept Urol, Fuzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 7, Res Ctr, Shenzhen, Peoples R China
[4] Jinan Univ, Maternal & Child Hlth Res Inst, Baoan Womens & Childrens Hosp, Shenzhen, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
clear cell renal cell carcinoma; the tumor microenvironment; chromatin accessibility; transcription factor; immune cell infiltration; MICROENVIRONMENT;
D O I
10.3389/fonc.2021.575425
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Recent research of clear cell renal cell carcinoma (ccRCC) is focused on the tumor immune microenvironment (TIME). Chromatin accessibility is critical for regulation of gene expression. However, its role in different immunological subtypes of ccRCC based on immune cell infiltration has not been systematically studied. Methods Five hundred thirty patient data from The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma (TCGA-KIRC) were adopted to estimate immune cell infiltration. Twenty-four types of immune cells were evaluated with single-sample Gene Set Enrichment Analysis (ssGSEA). Patients were divided into two clusters based on immune cell infiltration. Systematic chromatin accessibility analysis was conducted based on the two clusters. Results We compared the relative expression of the immune gene signatures among 530 patients of TCGA-KIRC using ssGSEA. Overall survival (OS) analysis revealed 10 types of immune cells were significantly associated with prognosis. Patients were divided into two clusters based on 24 types of immune cell infiltration. Immune cell signals as well as PD-1/PD-L1 signal were higher in cluster 1. Among the two clusters, 2,400 differential peaks were found in TCGA-KIRC Transposase Accessible Chromatin with high-throughput sequencing (ATAC-seq) data. The distribution of differential peaks and prognosis-related immune cells in 23 chromosomes are essentially the same. There is no peak distribution downstream. The proportion of peaks upstream of the 5' transcription start site decreases, and both sides of binding regions of the TSS 0.1-1 kb becomes smaller. Enrichment analysis of GO and KEGG of these differential peaks showed that they are remarkably related to the immune regulation in tumor microenvironment. Known motifs and de novo motifs were found by linking motif annotations to different peaks. Survival analysis of related motif transcription factors were prognostic. The GSEA enrichment analysis showed that high SP1 expression positively correlates with TGF-beta signaling and inflammatory response, while negatively correlates with TNF-alpha signaling via NFKB. High KLF12 expression negatively correlates with interferon gamma response, IL2-STAT5 signaling, TNF-alpha signaling via NFKB, IL6-JAK-STAT3 signaling. Conclusion The abnormality of chromatin accessibility may play an important regulatory role in ccRCC immunity.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Alterations in chromatin accessibility and DNA methylation in clear cell renal cell carcinoma
    M J Buck
    L M Raaijmakers
    S Ramakrishnan
    D Wang
    S Valiyaparambil
    S Liu
    N J Nowak
    R Pili
    Oncogene, 2014, 33 : 4961 - 4965
  • [2] Alterations in chromatin accessibility and DNA methylation in clear cell renal cell carcinoma
    Buck, M. J.
    Raaijmakers, L. M.
    Ramakrishnan, S.
    Wang, D.
    Valiyaparambil, S.
    Liu, S.
    Nowak, N. J.
    Pili, R.
    ONCOGENE, 2014, 33 (41) : 4961 - 4965
  • [3] Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
    Meng, Meng
    Lan, Tianjun
    Tian, Duanqing
    Qin, Zeman
    Li, Yu
    Li, Jinsong
    Cao, Haotian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Defining molecular subtypes of clear cell renal cell carcinoma
    Rathmell, W. Kimryn
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S62 - S62
  • [5] Identification of neoantigens and immunological subtypes in clear cell renal cell carcinoma for mRNA vaccine development and patient selection
    Zhu, Daoqi
    Yang, Jiabin
    Zhang, Minyi
    Han, Zhongxiao
    Shao, Meng
    Fan, Qin
    Ma, Yun
    Xie, Dandan
    Xiao, Wei
    AGING-US, 2023, 15 (11): : 5190 - 5214
  • [6] Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma
    Liu, Yifu
    Zhang, Zhicheng
    Xi, Ping
    Chen, Ru
    Cheng, Xiaofeng
    Liu, Ji
    Zhu, Qiqi
    Nie, Yechen
    Sun, Ting
    Gong, Binbin
    Wang, Siyuan
    BMC CANCER, 2023, 23 (01)
  • [7] Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma
    Yifu Liu
    Zhicheng Zhang
    Ping Xi
    Ru Chen
    Xiaofeng Cheng
    Ji Liu
    Qiqi Zhu
    Yechen Nie
    Ting Sun
    Binbin Gong
    Siyuan Wang
    BMC Cancer, 23
  • [8] Simultaneous evaluation of chromatin accessibility and DNA methylation in clear cell renal cell carcinoma by a newly developed assay, AcceSssIble
    Becket, Elinne
    Duymich, Christopher
    Chang, Yin-Wei
    Pandiyan, Kurinji
    Jones, Peter A.
    Liang, Gangning
    CANCER RESEARCH, 2014, 74 (19)
  • [9] A signature based on chromatin regulation and tumor microenvironment infiltration in clear cell renal cell carcinoma
    Yang, Chen
    Yu, Tian
    Lin, Qin
    EPIGENOMICS, 2022, 14 (17) : 995 - 1014
  • [10] The significance of the malfunction of the chromatin remodeling machinery in clear cell renal cell carcinoma
    Szurmak, J.
    Wilga, M.
    Cwiek, P.
    Stachowiak, M.
    Sarnowska, E.
    Sarnowski, T.
    FEBS OPEN BIO, 2024, 14 : 250 - 250